Goldman Sachs analyst David Roman downgraded Baxter (BAX) to Neutral from Buy with a price target of $25, down from $37.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Cautious Outlook for Baxter International Amid Weaker MPT Performance and Revised Growth Expectations
- Baxter sees Q3 adjusted EPS 58c-62c, consensus 64c
- Baxter cuts FY25 adjusted EPS view to $2.42-$2.52 from $2.47-$2.55
- Baxter reports Q2 adjusted EPS 54c, consensus 61c
- BAX Earnings this Week: How Will it Perform?